Capha Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was CAD 0.020879 million compared to CAD 0.017104 million a year ago.
For the nine months, net loss was CAD 0.058133 million compared to CAD 0.041319 million a year ago.